Figure 2.
Illustration on the relevance of immunotherapy in combination with topo-active drugs to suppress drug resistance in cancer cells. Tumor-infiltrating lymphocyte (TIL) therapy; topoisomerase-active drugs (topo-active drugs).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.